News: Rockwell Medical Inc (RMTI.OQ)
RMTI.OQ on NASDAQ Stock Exchange Global Market
4.98USD
1 Aug 2013
4.98USD
1 Aug 2013
Price Change (% chg)
$-0.07 (-1.39%)
$-0.07 (-1.39%)
Prev Close
$5.05
$5.05
Open
$5.08
$5.08
Day's High
$5.08
$5.08
Day's Low
$4.83
$4.83
Volume
119,940
119,940
Avg. Vol
214,509
214,509
52-wk High
$9.50
$9.50
52-wk Low
$3.16
$3.16
Select another date:
Thu, Jul 11 2013
Rockwell Medical's iron deficiency drug succeeds in trial
- Rockwell Medical Inc said a late-stage trial of its experimental iron deficiency drug met the main goal of improving hemoglobin levels in patients with chronic kidney disease.
Rockwell Medical's iron deficiency drug succeeds in trial
July 11 - Rockwell Medical Inc said a late-stage trial of its experimental iron deficiency drug met the main goal of improving patients' hemoglobin levels.
Rockwell Medical reports positive data on iron deficiency drug
- Rockwell Medical Inc reported positive results from a clinical study of its iron deficiency treatment for patients on hemodialysis.
UPDATE 1-Rockwell Medical reports positive data on iron deficiency drug
Feb 4 - Rockwell Medical Inc reported positive results from a clinical study of its iron deficiency treatment for patients on hemodialysis.
BRIEF-Rockwell Medical jumps 24 percent in premarket
NEW YORK, Feb 4 - Rockwell Medical Inc : * Shares jump 24 percent in premarket trading after drug trial results
Select another date:
- A Hidden Reason Rockwell Medical's Future Looks Bright
- Rockwell Medical: Undervalued After CRUISE-1 Results
- Rockwell Medical CRUISE Data Is Positive - Implications For The Next Move
- Rockwell Medical, Inc. - Special Call
- Rockwell Medical: Short Thesis Has Played Out... Time To Re-Examine
- Multiple Pending Catalysts Should Keep Investor Interest Strong For Rockwell Medical
Press Releases
- Rockwell Medical Data Safety Monitoring Board Recommends SFP Phase III Efficacy Studies to Continue as Planned
- Rockwell Medical Reports Third Quarter 2012 Results
- Rockwell Medical Schedules Conference Call Reporting Third Quarter Results
- Rockwell Medical to Present at Stifel Nicolaus Healthcare Conference
- Rockwell Medical Receives Canadian Patent for SFP Formulation for Iron-Delivery in Hemodialysis Patients
- Rockwell Medical Reports Second Quarter 2012 Results
- Rockwell Medical Completes Patient Enrollment in Phase III Clinical Trials for SFP Iron-Delivery in Hemodialysis Patients
- Rockwell Medical Schedules Conference Call Reporting Second Quarter Results
- Rockwell Medical Schedules Conference Call Reporting Second Quarter Results
- Life Sciences Companies Webcast Live to Online Investors, July 12th, at RetailInvestorConferences.com

